InsiderTrades

Form 4 for UTHR UNITED THERAPEUTICS Corp

Accepted 2025-10-31 00:00:00 ET · period of report 2025-10-29 · accession 0001106578-25-000025 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMT 2025-10-31 2025-10-29+ UTHR ROTHBLATT MARTINE A COB, CEO, Dir M - OptEx $120.26 +8,000 4,130 New +$962.1K
DMT 2025-10-31 2025-10-29+ UTHR ROTHBLATT MARTINE A COB, CEO, Dir S - Sale+OE $442.37 -8,000 2,089 -79% -$3.54M
DMT 2025-10-31 2025-10-29+ UTHR ROTHBLATT MARTINE A COB, CEO, Dir M - OptEx $0.00 -8,000 142.0K -5% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-10-30 M A 4,000 $120.26 4,130 D — —
2 Common Common Stock 2025-10-29 S D 1,100 $433.31 3,030 D — —
3 Common Common Stock 2025-10-29 M A 4,000 $120.26 4,130 D — —
4 Common Common Stock 2025-10-30 S D 1,459 $450.23 630 D — — (F2) This transaction was executed in multiple trades at prices ranging from $450.115 to $450.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
5 Common Common Stock 2025-10-30 S D 1,500 $447.14 2,630 D — —
6 Common Common Stock 2025-10-29 S D 900 $439.99 130 D — —
7 Common Common Stock 2025-10-30 S D 500 $451.29 130 D — —
8 Common Common Stock 2025-10-29 S D 2,000 $435.24 1,030 D — —
9 Common Common Stock 2025-10-30 S D 541 $448.43 2,089 D — —
10 Derivative Stock Option 2025-10-30 M D 4,000 $0.00 138,000 D $120.26 · 2016-03-15 to 2026-03-15 4,000 Common Stock
11 Derivative Stock Option 2025-10-29 M D 4,000 $0.00 142,000 D $120.26 · 2016-03-15 to 2026-03-15 4,000 Common Stock